Annual SGA
$5.25 M
-$596.80 K-10.21%
June 30, 2024
Summary
- As of February 7, 2025, INM annual SGA is $5.25 million, with the most recent change of -$596.80 thousand (-10.21%) on June 30, 2024.
- During the last 3 years, INM annual SGA has risen by +$771.40 thousand (+17.22%).
- INM annual SGA is now -23.54% below its all-time high of $6.87 million, reached on June 30, 2022.
Performance
INM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.42 M
+$208.00 K+17.13%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly SGA is $1.42 million, with the most recent change of +$208.00 thousand (+17.13%) on September 30, 2024.
- Over the past year, INM quarterly SGA has increased by +$47.80 thousand (+3.48%).
- INM quarterly SGA is now -25.75% below its all-time high of $1.92 million, reached on March 31, 2022.
Performance
INM Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$432.38 M
-$6.82 M-1.60%
September 30, 2024
Summary
- As of February 7, 2025, INM TTM SGA is -$432.38 million, with the most recent change of -$6.82 million (-1.60%) on September 30, 2024.
- Over the past year, INM TTM SGA has dropped by -$437.83 million (-8039.16%).
- INM TTM SGA is now -4835.99% below its all-time high of -$8.76 million.
Performance
INM TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
INM Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.2% | +3.5% | -8039.2% |
| 3 y3 years | +17.2% | -18.4% | -6396.4% |
| 5 y5 years | -12.5% | +48.2% | -10000.0% |
INM Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.5% | +17.2% | -25.8% | +17.1% | -41.1% | at low |
| 5 y | 5-year | -23.5% | +62.7% | -25.8% | +151.4% | -115.5% | at low |
| alltime | all time | -23.5% | >+9999.0% | -25.8% | >+9999.0% | -4836.0% | at low |
InMed Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.42 M(+17.1%) | $5.37 M(+2.3%) |
| Jun 2024 | $5.25 M(-10.2%) | $1.21 M(-11.7%) | $5.25 M(-3.6%) |
| Mar 2024 | - | $1.37 M(+0.7%) | $5.45 M(-0.7%) |
| Dec 2023 | - | $1.36 M(+5.0%) | $5.48 M(-1.8%) |
| Sep 2023 | - | $1.30 M(-7.9%) | $5.59 M(-4.5%) |
| Jun 2023 | $5.85 M(-14.8%) | $1.41 M(-0.2%) | $5.85 M(-5.4%) |
| Mar 2023 | - | $1.41 M(-3.6%) | $6.18 M(-7.5%) |
| Dec 2022 | - | $1.46 M(-6.1%) | $6.68 M(-5.3%) |
| Sep 2022 | - | $1.56 M(-10.4%) | $7.05 M(+2.7%) |
| Jun 2022 | $6.87 M(+53.3%) | $1.74 M(-9.0%) | $6.87 M(+2.7%) |
| Mar 2022 | - | $1.92 M(+4.3%) | $6.69 M(+9.5%) |
| Dec 2021 | - | $1.84 M(+33.8%) | $6.10 M(+16.8%) |
| Sep 2021 | - | $1.37 M(-12.1%) | $5.23 M(+16.7%) |
| Jun 2021 | $4.48 M(+38.8%) | $1.56 M(+17.1%) | $4.48 M(+28.6%) |
| Mar 2021 | - | $1.33 M(+39.0%) | $3.48 M(+14.1%) |
| Dec 2020 | - | $959.60 K(+53.6%) | $3.05 M(+3.0%) |
| Sep 2020 | - | $624.80 K(+10.5%) | $2.96 M(-8.1%) |
| Jun 2020 | $3.23 M(-46.2%) | $565.60 K(-37.3%) | $3.23 M(-21.8%) |
| Mar 2020 | - | $902.30 K(+3.5%) | $4.13 M(-10.9%) |
| Dec 2019 | - | $871.70 K(-1.8%) | $4.63 M(-10.7%) |
| Sep 2019 | - | $887.50 K(-39.4%) | $5.19 M(-14.0%) |
| Jun 2019 | $6.00 M(+20.3%) | $1.46 M(+4.0%) | $6.03 M(-5.7%) |
| Mar 2019 | - | $1.41 M(-1.4%) | $6.40 M(+3.0%) |
| Dec 2018 | - | $1.43 M(-17.5%) | $6.21 M(+9.8%) |
| Sep 2018 | - | $1.73 M(-5.4%) | $5.65 M(+11.7%) |
| Jun 2018 | $4.99 M(+78.8%) | $1.83 M(+50.2%) | $5.06 M(+14.9%) |
| Mar 2018 | - | $1.22 M(+39.5%) | $4.40 M(+11.2%) |
| Dec 2017 | - | $873.30 K(-23.3%) | $3.96 M(+8.7%) |
| Sep 2017 | - | $1.14 M(-2.9%) | $3.64 M(+30.6%) |
| Jun 2017 | $2.79 M(+88.9%) | $1.17 M(+51.0%) | $2.79 M(+43.0%) |
| Mar 2017 | - | $776.40 K(+39.5%) | $1.95 M(+37.6%) |
| Dec 2016 | - | $556.50 K(+95.4%) | $1.42 M(+10.5%) |
| Sep 2016 | - | $284.80 K(-14.8%) | $1.28 M(-10.4%) |
| Jun 2016 | $1.48 M(-43.6%) | $334.20 K(+37.4%) | $1.43 M(-29.0%) |
| Mar 2016 | - | $243.30 K(-42.3%) | $2.02 M(-24.0%) |
| Dec 2015 | - | $421.70 K(-2.8%) | $2.65 M(+0.6%) |
| Sep 2015 | - | $433.90 K(-52.7%) | $2.64 M(-3.0%) |
| Jun 2015 | $2.62 M(+139.5%) | $918.30 K(+4.5%) | $2.72 M(-2.4%) |
| Mar 2015 | - | $879.10 K(+117.1%) | $2.78 M(+40.4%) |
| Dec 2014 | - | $404.90 K(-21.2%) | $1.98 M(+23.9%) |
| Sep 2014 | - | $514.10 K(-47.8%) | $1.60 M(+45.9%) |
| Jun 2014 | $1.09 M(+2243.5%) | $984.10 K(+1150.4%) | $1.10 M(+714.2%) |
| Mar 2014 | - | $78.70 K(+256.1%) | $134.60 K(+112.0%) |
| Dec 2013 | - | $22.10 K(+100.9%) | $63.50 K(+79.4%) |
| Sep 2013 | - | $11.00 K(-51.8%) | $35.40 K(-25.2%) |
| Jun 2013 | $46.70 K | $22.80 K(+200.0%) | $47.30 K(-43.8%) |
| Mar 2013 | - | $7600.00(-226.7%) | $84.10 K(-15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | - | -$6000.00(-126.2%) | $99.20 K(-24.6%) |
| Sep 2012 | - | $22.90 K(-61.6%) | $131.50 K(-12.0%) |
| Jun 2012 | $151.60 K(-47.2%) | $59.60 K(+162.6%) | $149.40 K(+19.8%) |
| Mar 2012 | - | $22.70 K(-13.7%) | $124.70 K(-60.5%) |
| Dec 2011 | - | $26.30 K(-35.5%) | $315.70 K(+3.7%) |
| Sep 2011 | - | $40.80 K(+16.9%) | $304.30 K(+6.7%) |
| Jun 2011 | $287.00 K(-4.6%) | $34.90 K(-83.7%) | $285.20 K(-20.6%) |
| Mar 2011 | - | $213.70 K(+1334.2%) | $359.20 K(+75.4%) |
| Dec 2010 | - | $14.90 K(-31.3%) | $204.80 K(-18.3%) |
| Sep 2010 | - | $21.70 K(-80.1%) | $250.80 K(-15.2%) |
| Jun 2010 | $300.70 K(-36.0%) | $108.90 K(+83.6%) | $295.90 K(+62.8%) |
| Mar 2010 | - | $59.30 K(-2.6%) | $181.80 K(-7.2%) |
| Dec 2009 | - | $60.90 K(-8.8%) | $196.00 K(-44.2%) |
| Sep 2009 | - | $66.80 K(-1384.6%) | $351.20 K(-31.8%) |
| Jun 2009 | $469.50 K(-59.8%) | -$5200.00(-107.1%) | $514.60 K(-49.3%) |
| Mar 2009 | - | $73.50 K(-66.0%) | $1.02 M(-10.0%) |
| Dec 2008 | - | $216.10 K(-6.1%) | $1.13 M(-7.2%) |
| Sep 2008 | - | $230.20 K(-53.6%) | $1.22 M(-11.3%) |
| Jun 2008 | $1.17 M(-8.5%) | $495.90 K(+165.5%) | $1.37 M(+5.9%) |
| Mar 2008 | - | $186.80 K(-38.5%) | $1.30 M(-4.1%) |
| Dec 2007 | - | $303.50 K(-21.3%) | $1.35 M(+2.3%) |
| Sep 2007 | - | $385.50 K(-8.1%) | $1.32 M(+12.5%) |
| Jun 2007 | $1.28 M(-43.6%) | $419.60 K(+73.7%) | $1.17 M(+11.9%) |
| Mar 2007 | - | $241.60 K(-11.7%) | $1.05 M(-23.3%) |
| Dec 2006 | - | $273.50 K(+14.3%) | $1.37 M(-22.0%) |
| Sep 2006 | - | $239.30 K(-18.9%) | $1.76 M(-17.5%) |
| Jun 2006 | $2.26 M(-12.2%) | $295.20 K(-47.4%) | $2.13 M(-17.2%) |
| Mar 2006 | - | $561.30 K(-15.0%) | $2.57 M(+4.0%) |
| Dec 2005 | - | $660.50 K(+7.7%) | $2.47 M(+4.2%) |
| Sep 2005 | - | $613.10 K(-16.9%) | $2.38 M(-7.3%) |
| Jun 2005 | $2.58 M(+40.2%) | $738.20 K(+59.5%) | $2.56 M(-3.0%) |
| Mar 2005 | - | $462.90 K(-17.5%) | $2.64 M(+6.5%) |
| Dec 2004 | - | $561.40 K(-29.9%) | $2.48 M(+7.5%) |
| Sep 2004 | - | $801.10 K(-2.0%) | $2.31 M(+22.7%) |
| Jul 2004 | $1.84 M(+84.7%) | $817.20 K(+171.7%) | $1.88 M(+24.6%) |
| Apr 2004 | - | $300.80 K(-22.3%) | $1.51 M(+9.2%) |
| Jan 2004 | - | $387.30 K(+3.4%) | $1.38 M(+18.3%) |
| Oct 2003 | - | $374.50 K(-16.1%) | $1.17 M(+20.4%) |
| Jul 2003 | $995.70 K(+10.3%) | $446.30 K(+157.8%) | $969.40 K(+47.3%) |
| Apr 2003 | - | $173.10 K(-0.1%) | $658.20 K(-7.0%) |
| Jan 2003 | - | $173.20 K(-2.0%) | $707.70 K(-11.3%) |
| Oct 2002 | - | $176.80 K(+30.9%) | $797.50 K(-11.0%) |
| Jul 2002 | $902.70 K(-76.9%) | $135.10 K(-39.3%) | $896.40 K(+17.7%) |
| Apr 2002 | - | $222.60 K(-15.4%) | $761.30 K(+41.3%) |
| Jan 2002 | - | $263.00 K(-4.6%) | $538.70 K(+95.4%) |
| Oct 2001 | - | $275.70 K | $275.70 K |
| Jul 2001 | $3.91 M | - | - |
FAQ
- What is InMed Pharmaceuticals annual SGA?
- What is the all time high annual SGA for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual SGA year-on-year change?
- What is InMed Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly SGA year-on-year change?
- What is InMed Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals TTM SGA year-on-year change?
What is InMed Pharmaceuticals annual SGA?
The current annual SGA of INM is $5.25 M
What is the all time high annual SGA for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual SGA is $6.87 M
What is InMed Pharmaceuticals annual SGA year-on-year change?
Over the past year, INM annual SGA has changed by -$596.80 K (-10.21%)
What is InMed Pharmaceuticals quarterly SGA?
The current quarterly SGA of INM is $1.42 M
What is the all time high quarterly SGA for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly SGA is $1.92 M
What is InMed Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, INM quarterly SGA has changed by +$47.80 K (+3.48%)
What is InMed Pharmaceuticals TTM SGA?
The current TTM SGA of INM is -$432.38 M
What is the all time high TTM SGA for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high TTM SGA is -$8.76 M
What is InMed Pharmaceuticals TTM SGA year-on-year change?
Over the past year, INM TTM SGA has changed by -$437.83 M (-8039.16%)